155 related articles for article (PubMed ID: 34090666)
1. Melanoma with osseous or chondroid differentiation: a report of eight cases including SATB2 expression and mutation analysis.
Gallagher SJ; Bailey T; Rawson RV; Mahar AM; Thompson JF; Long GV; Wilmott JS; Scolyer RA
Pathology; 2021 Dec; 53(7):830-835. PubMed ID: 34090666
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of MiTF staining in undifferentiated pleomorphic sarcoma: caution in the use of melanocytic markers in sarcoma.
Choy B; Hyjek E; Montag AG; Pytel P; Haydon R; Luu HH; Zhen CJ; Long BC; Kadri S; Segal JP; Furtado LV; Cipriani NA
Histopathology; 2017 Apr; 70(5):734-745. PubMed ID: 27926791
[TBL] [Abstract][Full Text] [Related]
3. Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.
Thomas NE; Edmiston SN; Alexander A; Groben PA; Parrish E; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; From L; Busam KJ; Hao H; Orlow I; Kanetsky PA; Luo L; Reiner AS; Paine S; Frank JS; Bramson JI; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Conway K;
JAMA Oncol; 2015 Jun; 1(3):359-68. PubMed ID: 26146664
[TBL] [Abstract][Full Text] [Related]
4. Primary intra-abdominal melanoma arising in association with extracutaneous blue naevus: a report of two cases.
Shah K; Folpe AL; Miller M; Morgan JA; Raut CP; Doyle LA
Histopathology; 2021 Jan; 78(2):281-289. PubMed ID: 32698251
[TBL] [Abstract][Full Text] [Related]
5. Integrating Next-Generation Sequencing with Morphology Improves Prognostic and Biologic Classification of Spitz Neoplasms.
Quan VL; Zhang B; Zhang Y; Mohan LS; Shi K; Wagner A; Kruse L; Taxter T; Beaubier N; White K; Zou L; Gerami P
J Invest Dermatol; 2020 Aug; 140(8):1599-1608. PubMed ID: 32004563
[TBL] [Abstract][Full Text] [Related]
6. Metastatic Malignant Melanoma With Complete Loss of Differentiation Markers (Undifferentiated/Dedifferentiated Melanoma): Analysis of 14 Patients Emphasizing Phenotypic Plasticity and the Value of Molecular Testing as Surrogate Diagnostic Marker.
Agaimy A; Specht K; Stoehr R; Lorey T; Märkl B; Niedobitek G; Straub M; Hager T; Reis AC; Schilling B; Schneider-Stock R; Hartmann A; Mentzel T
Am J Surg Pathol; 2016 Feb; 40(2):181-91. PubMed ID: 26448190
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic lessons of mucosal melanoma with osteocartilaginous differentiation.
Banerjee SS; Coyne JD; Menasce LP; Lobo CJ; Hirsch PJ
Histopathology; 1998 Sep; 33(3):255-60. PubMed ID: 9777392
[TBL] [Abstract][Full Text] [Related]
8. Molecular Profiling of Noncoding Mutations Distinguishes Nevoid Melanomas From Mitotically Active Nevi in Pregnancy.
Jackett LA; Colebatch AJ; Rawson RV; Ferguson PM; Thompson JF; McCarthy SW; Wilmott JS; Scolyer RA
Am J Surg Pathol; 2020 Mar; 44(3):357-367. PubMed ID: 31743128
[TBL] [Abstract][Full Text] [Related]
9. Expression of SATB2 in primary cutaneous sarcomatoid neoplasms: a potential diagnostic pitfall.
Szczepanski JM; Siddiqui J; Patel RM; Harms PW; Hrycaj SM; Chan MP
Pathology; 2023 Apr; 55(3):350-354. PubMed ID: 36732203
[TBL] [Abstract][Full Text] [Related]
10. The clinicopathologic spectrum and genomic landscape of de-/trans-differentiated melanoma.
Ferreira I; Droop A; Edwards O; Wong K; Harle V; Habeeb O; Gharpuray-Pandit D; Houghton J; Wiedemeyer K; Mentzel T; Billings SD; Ko JS; Füzesi L; Mulholland K; Prusac IK; Liegl-Atzwanger B; de Saint Aubain N; Caldwell H; Riva L; van der Weyden L; Arends MJ; Brenn T; Adams DJ
Mod Pathol; 2021 Nov; 34(11):2009-2019. PubMed ID: 34155350
[TBL] [Abstract][Full Text] [Related]
11. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers.
Miettinen M; Fernandez M; Franssila K; Gatalica Z; Lasota J; Sarlomo-Rikala M
Am J Surg Pathol; 2001 Feb; 25(2):205-11. PubMed ID: 11176069
[TBL] [Abstract][Full Text] [Related]
12. Sarcomatoid Dedifferentiated Melanoma: The Diagnostic Role of Next-Generation Sequencing.
Valiga AA; Fuller CG; Doyle JA; Lee JB
Am J Dermatopathol; 2022 Apr; 44(4):282-286. PubMed ID: 34726188
[TBL] [Abstract][Full Text] [Related]
13. Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system.
van de Nes J; Gessi M; Sucker A; Möller I; Stiller M; Horn S; Scholz SL; Pischler C; Stadtler N; Schilling B; Zimmer L; Hillen U; Scolyer RA; Buckland ME; Lauriola L; Pietsch T; Waha A; Schadendorf D; Murali R; Griewank KG
J Neurooncol; 2016 May; 127(3):435-44. PubMed ID: 26744134
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of eight melanocytic and neural crest-associated markers in a well-characterised series of 124 malignant peripheral nerve sheath tumours (MPNST): useful to distinguish MPNST from melanoma?
Gaspard M; Lamant L; Tournier E; Valentin T; Rochaix P; Terrier P; Ranchere-Vince D; Coindre JM; Filleron T; Le Guellec S
Histopathology; 2018 Dec; 73(6):969-982. PubMed ID: 30137667
[TBL] [Abstract][Full Text] [Related]
15. Micropthalmia transcription factor (MITF) as a diagnostic marker for metastatic melanomas negative for other melanoma markers.
Guo R; Franco-Palacios M; Russell M; Goddard L; Hassell L; Gillies E; Fung KM
Int J Clin Exp Pathol; 2013; 6(8):1658-64. PubMed ID: 23923085
[TBL] [Abstract][Full Text] [Related]
16. Clinical and genetic analysis of melanomas arising in acral sites.
Zaremba A; Murali R; Jansen P; Möller I; Sucker A; Paschen A; Zimmer L; Livingstone E; Brinker TJ; Hadaschik E; Franklin C; Roesch A; Ugurel S; Schadendorf D; Griewank KG; Cosgarea I
Eur J Cancer; 2019 Sep; 119():66-76. PubMed ID: 31419753
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological characteristics and mutation profiling in primary cutaneous melanoma.
Yaman B; Akalin T; Kandiloğlu G
Am J Dermatopathol; 2015 May; 37(5):389-97. PubMed ID: 25357015
[TBL] [Abstract][Full Text] [Related]
18. Molecular and genetic diversity in the metastatic process of melanoma.
Harbst K; Lauss M; Cirenajwis H; Winter C; Howlin J; Törngren T; Kvist A; Nodin B; Olsson E; Häkkinen J; Jirström K; Staaf J; Lundgren L; Olsson H; Ingvar C; Gruvberger-Saal SK; Saal LH; Jönsson G
J Pathol; 2014 May; 233(1):39-50. PubMed ID: 24399611
[TBL] [Abstract][Full Text] [Related]
19. Immunoprofile of MITF, tyrosinase, melan-A, and MAGE-1 in HMB45-negative melanomas.
Xu X; Chu AY; Pasha TL; Elder DE; Zhang PJ
Am J Surg Pathol; 2002 Jan; 26(1):82-7. PubMed ID: 11756773
[TBL] [Abstract][Full Text] [Related]
20. NF1 Mutations Are Common in Desmoplastic Melanoma.
Wiesner T; Kiuru M; Scott SN; Arcila M; Halpern AC; Hollmann T; Berger MF; Busam KJ
Am J Surg Pathol; 2015 Oct; 39(10):1357-62. PubMed ID: 26076063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]